Literature DB >> 25427953

Effects of strain and age on hepatic gene expression profiles in murine models of HFE-associated hereditary hemochromatosis.

Seung-Min Lee1, Alexandre Loguinov, Robert E Fleming, Christopher D Vulpe.   

Abstract

Hereditary hemochromatosis is an iron overload disorder most commonly caused by a defect in the HFE gene. While the genetic defect is highly prevalent, the majority of individuals do not develop clinically significant iron overload, suggesting the importance of genetic modifiers. Murine hfe knockout models have demonstrated that strain background has a strong effect on the severity of iron loading. We noted that hepatic iron loading in hfe-/- mice occurs primarily over the first postnatal weeks (loading phase) followed by a timeframe of relatively static iron concentrations (plateau phase). We thus evaluated the effects of background strain and of age on hepatic gene expression in Hfe knockout mice (hfe-/-). Hepatic gene expression profiles were examined using cDNA microarrays in 4- and 8-week-old hfe-/- and wild-type mice on two different genetic backgrounds, C57BL/6J (C57) and AKR/J (AKR). Genes differentially regulated in all hfe-/- mice groups, compared with wild-type mice, including those involved in cell survival, stress and damage responses and lipid metabolism. AKR strain-specific changes in lipid metabolism genes and C57 strain-specific changes in cell adhesion and extracellular matrix protein genes were detected in hfe-/- mice. Mouse strain and age are each significantly associated with hepatic gene expression profiles in hfe-/- mice. These affects may underlie or reflect differences in iron loading in these mice.

Entities:  

Year:  2014        PMID: 25427953      PMCID: PMC4245401          DOI: 10.1007/s12263-014-0443-1

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  54 in total

Review 1.  Mechanisms of iron accumulation in hereditary hemochromatosis.

Authors:  Robert E Fleming; William S Sly
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

2.  Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice.

Authors:  C Pigeon; B Turlin; T C Iancu; P Leroyer; J Le Lan; Y Deugnier; P Brissot; O Loréal
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

3.  A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  M L Rasmussen; A R Folsom; D J Catellier; M Y Tsai; U Garg; J H Eckfeldt
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

4.  Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.

Authors:  Martina Muckenthaler; Cindy N Roy; Angel O Custodio; Belén Miñana; Jos deGraaf; Lynne K Montross; Nancy C Andrews; Matthias W Hentze
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

5.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

6.  Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines.

Authors:  H W Hann; M W Stahlhut; C L Hann
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

Review 7.  Hemochromatosis: genetics and pathophysiology.

Authors:  Ernest Beutler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

8.  Population screening for hemochromatosis: a study in 5370 Spanish blood donors.

Authors:  Mayka Sánchez; Margarita Villa; Mercedes Ingelmo; Cristina Sanz; Miquel Bruguera; Carlos Ascaso; Rafael Oliva
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

9.  Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.

Authors:  Núria Aranda; Fernando E Viteri; Carme Montserrat; Victoria Arija
Journal:  Ann Hematol       Date:  2010-01-28       Impact factor: 3.673

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  1 in total

Review 1.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.